LRRC25 and cancer: Recent studies also supported the immunological mechanism of action of P-MAPA through the activation of TLR2 and TLR4 signaling in both cancer and infections, in addition to regulating the activity of T cells (especially CD4+T and CD8+T cells) and natural killer (NK) cells [9,10].